Humira
- Product NDC
- 50090-3530
- 11-digit product format
- 500903530
- Labeler code
- 50090
- Product ID
- 50090-3530_414988b4-9b35-45c5-a0e7-e6173339e8d3
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Adalimumab
- Dosage form
- KIT
- Labeler
- A-S Medication Solutions
- Application
- BLA125057
- Marketing category
- BLA
- Marketing start
- 2006-06-23
- Marketing end
- 0000-00-00
- Active strength
- 0
- NDC exclude flag
- No
- Listing certified through
- 2019-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 50090-3530 | D | Discontinued by firm | 2026-07-31 | ||
| excluded package | package | 50090-3530 | 50090-3530-0 | D | Discontinued by firm | 2026-07-31 |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Humira | ADALIMUMAB | Cordavis Limited | 4977567e-3525-44ac-9ff5-f1e74b053950 | 2025-12-23 | Boxed warning, Warnings, Adverse reactions | BLA125057 |
| Humira | ADALIMUMAB | AbbVie Inc. | 608d4f0d-b19f-46d3-749a-7159aa5f933d | 2025-12-23 | Boxed warning, Warnings, Adverse reactions | BLA125057 |
| HUMIRA | ADALIMUMAB | A-S Medication Solutions | a06a9aec-fd5b-4c3e-a81f-eb46bb384100 | 2024-05-16 | Boxed warning, Warnings, Adverse reactions | BLA125057 |
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 125057 | Humira | adalimumab | 351(a) | Rx | 2026-06-01 |